Evidence map›Paper›PMID 38221679›Full record

ArticlePediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society

First Reported Histologically and Molecularly Confirmed Bilateral High-Grade Serous Ovarian Adenocarcinoma Metastasized to Placental Decidua of the Membranes.

Salma El Emrani, Linda S Nooij, Chiara C M M Lap, Lotte E van der Meeren

Abstract readCase Reports
In one paragraph

Article in Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Salma El EmraniDepartment of Neonatology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.ORCID 0000-0002-0571-2256
Linda S NooijDepartment of Gynecology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.
Chiara C M M LapDepartment of Gynecology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.
Lotte E van der MeerenDepartment of Pathology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.ORCID 0000-0002-4537-5645

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 43-year-old female presented with blood loss and persistent abdominal pain at 14 weeks of gestation. Ultrasound examination and subsequent magnetic resonance imaging (MRI) revealed bilateral multicystic uterine adnexa. Exploratory laparotomy was performed at 17 weeks of gestation and bilateral serous ovarian adenocarcinoma FIGO stage IIIC was diagnosed. Complete cytoreductive surgery (CRS) was not feasible at that moment. Nine days after the exploratory laparotomy, immature rupture of membranes and contractions occurred and she delivered a premature boy after 19 weeks of gestation. Pathological examination of the placenta revealed that her ovarian cancer metastasized to the membranes. We describe the first case of ovarian cancer metastasized to the decidua of the placental membranes with histological, immunohistochemical, and molecular confirmation. This case highlights the importance of conscientious evaluation of placenta and membranes in pregnant women with ovarian cancer.

Indexed as

Ovarian NeoplasmsPregnancy Complications, NeoplasticAdultBiomarkers, TumorCystadenocarcinoma, SerousDeciduaFemaleHumansPlacentaPregnancyBiomarkers, Tumormetastasisnext generation sequencing (NGS)ovarian carcinomaplacenta

Identifiers

PMID38221679
PMCPMC11088206

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.